Page last updated: 2024-11-13

staphyloxanthin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

staphyloxanthin: Staph aureus pigment; glucose esterified with both a triterpenoid carotenoid carboxylic acid & a C15 fatty acid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

staphyloxanthin : A xanthophyll that is beta-D-glucopyranose in which the hydroxy groups at positions 1 and 6 have been acylated by an all-trans-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenoyl group and a 12-methyltetradecanoyl group, respectively. Staphyloxanthin is responsible for the characteristic yellow-golden colour which gives the bacterium Staphylococcus aureus its name. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID56928085
CHEBI ID71690
MeSH IDM0099765

Synonyms (9)

Synonym
71869-01-7
staphyloxanthin
beta-d-glucopyranosyl 1-o-(4,4'-diaponeurosporen-4-oate)-6-o-(12-methyltetradecanoate)
CHEBI:71690
1-o-[(2e,4e,6e,8e,10e,12e,14e,16e,18e)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenoyl]-6-o-(12-methyltetradecanoyl)-beta-d-glucopyranose
alapha-d-glucopyranosyl 1-o-(4,4'-diaponeurosporen-4-oate) 6-o-(12-methyltetradecanoate)
8'-apo-psi,psi-carotenoic acid, 6-o-(12-methyl-1-oxotetradecyl)-alpha-d-glucopyranosyl ester
DTXSID20222141
alpha-d-glucopyranosyl 1-o-(4,4'-diaponeurosporen-4-oate)-o-(12-methyltetradecanoate)

Research Excerpts

Overview

Staphyloxanthin (STX) is a yellowish-orange carotenoid pigment synthesized by S. Staphylococcus aureus.

ExcerptReferenceRelevance
"Staphyloxanthin is a golden yellow color eponymous pigment produced by S."( Staphyloxanthin inhibitory potential of thymol impairs antioxidant fitness, enhances neutrophil mediated killing and alters membrane fluidity of methicillin resistant Staphylococcus aureus.
Muthuramalingam, P; Pandian, SK; Priya, A; Ramesh, M; Selvaraj, A; Valliammai, A, 2021
)
2.79
"Staphyloxanthin (STX) is a yellowish-orange carotenoid pigment synthesized by S."( Network analytics approach towards identifying potential antivirulence drug targets within the Staphylococcus aureus staphyloxanthin biosynthetic network.
Cueno, ME; Imai, K, 2018
)
1.41
"Staphyloxanthin is a membrane-bound carotenoid of Staphylococcus aureus. "( Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress.
Clauditz, A; Götz, F; Peschel, A; Resch, A; Wieland, KP, 2006
)
3.22

Actions

ExcerptReferenceRelevance
"Staphyloxanthin promotes resistance to oxidative stress and enhances bacterial survival in neutrophils."( Variable staphyloxanthin production by Staphylococcus aureus drives strain-dependent effects on diabetic wound-healing outcomes.
Bianco, C; Campbell, AE; Gardner, SE; Grice, EA; Knight, SAB; Lovins, VM; McCready-Vangi, AR; Morgenstern, AR; Murga-Garrido, SM; Pan, JT; Planet, PJ; Uberoi, A; White, EK, 2023
)
2.05
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
biological pigmentAn endogenous molecular entity that results in a colour of an organism as the consequence of the selective absorption of light.
virulence factorAny toxin secreted by bacteria, viruses, fungi or protozoa enabling them to achieve colonisation of a niche in the host, inhibit or evade the host's immune response, enter and exit cells, or obtain nutrition from the host.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
xanthophyllA subclass of carotenoids consisting of the oxygenated carotenes.
D-aldohexose derivativeAn aldohexose derivative that has D-configuration.
triolA chemical compound containing three hydroxy groups.
fatty acid esterA carboxylic ester in which the carboxylic acid component can be any fatty acid.
apo carotenoid triterpenoidA triterpenoid compound arising from loss of part of the carotene skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
staphyloxanthin biosynthesis421

Research

Studies (68)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (2.94)18.7374
1990's0 (0.00)18.2507
2000's10 (14.71)29.6817
2010's39 (57.35)24.3611
2020's17 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.04 (24.57)
Research Supply Index4.23 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other66 (97.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]